{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T18:10:06Z","timestamp":1768327806135,"version":"3.49.0"},"reference-count":42,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_med-2025-1371_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To identify causal genes for benign prostatic hyperplasia (BPH) based on single-cell RNA sequencing (scRNA-seq) and genome-wide association studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_med-2025-1371_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We explored scRNA-seq datasets to identify the differentially expressed genes (DEGs) in BPH patients vs. healthy controls. Mendelian randomization (MR) was conducted to investigate the causal relationships between the identified DEGs and BPH. Bayesian colocalization and reverse MR were performed to consolidate the MR findings. Potential therapeutic drugs targeting causal genes were explored via molecular docking. The results of bioinformatics analyses were validated through experiments including flow cytometry, quantitative reverse transcription polymerase chain reaction, western blotting, immunohistochemistry, and immunofluorescence staining.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_med-2025-1371_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      BPH patients showed an increased proportion of myeloid cells in the prostate transition zone, with 85 classical monocyte-specific DEGs. Among these, SLC25A37 was causally associated with BPH based on MR, Bayesian colocalization, and reverse MR analyses. Functional analyses indicated its involvement in proliferation-related signaling pathways in classical monocytes. Ferriheme chloride and catechol were identified as potential drugs targeting SLC25A37.\n                      <jats:italic>In vitro<\/jats:italic>\n                      study confirmed increased expression levels of SLC25A37 and myeloid cells in BPH tissues.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_med-2025-1371_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our integrative analyses revealed SLC25A37 as a novel causal gene in BPH pathogenesis, unveiling potential therapeutic strategies for BPH treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/med-2025-1371","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T12:02:08Z","timestamp":1768305728000},"source":"Crossref","is-referenced-by-count":0,"title":["SLC25A37 as a novel therapeutic target for benign prostatic hyperplasia: integrative analyses of single-cell RNA sequencing and genome-wide association studies"],"prefix":"10.1515","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-7175-5730","authenticated-orcid":false,"given":"Zhen","family":"Tong","sequence":"first","affiliation":[{"name":"Department of Urology , Renji Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2749-9814","authenticated-orcid":false,"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Urology , Renji Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6077-4855","authenticated-orcid":false,"given":"Xinrui","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Urology , Renji Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3437-0021","authenticated-orcid":false,"given":"Xinxing","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Urology , Renji Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0495-1834","authenticated-orcid":false,"given":"Zehong","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Urology , Renji Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7689-3237","authenticated-orcid":false,"given":"Liang","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Urology , Renji Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0124-9433","authenticated-orcid":false,"given":"Wei","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Urology , Renji Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai , China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"key":"2026011312015838949_j_med-2025-1371_ref_001","doi-asserted-by":"crossref","unstructured":"Chughtai, B, Forde, JC, Thomas, DDM, Laor, L, Hossack, T, Woo, HH, et al.. Benign prostatic hyperplasia. Nat Rev Dis Primers 2016;2:16031. https:\/\/doi.org\/10.1038\/nrdp.2016.31.","DOI":"10.1038\/nrdp.2016.31"},{"key":"2026011312015838949_j_med-2025-1371_ref_002","doi-asserted-by":"crossref","unstructured":"Zhu, C, Wang, DQ, Zi, H, Huang, Q, Gu, JM, Li, LY, et al.. Epidemiological trends of urinary tract infections, urolithiasis and benign prostatic hyperplasia in 203 countries and territories from 1990 to 2019. Mil Med Res 2021;8:64. https:\/\/doi.org\/10.1186\/s40779-021-00359-8.","DOI":"10.1186\/s40779-021-00359-8"},{"key":"2026011312015838949_j_med-2025-1371_ref_003","doi-asserted-by":"crossref","unstructured":"Lee, SWH, Chan, EMC, Lai, YK. The global burden of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a systematic review and meta-analysis. Sci Rep 2017;7:7984. https:\/\/doi.org\/10.1038\/s41598-017-06628-8.","DOI":"10.1038\/s41598-017-06628-8"},{"key":"2026011312015838949_j_med-2025-1371_ref_004","doi-asserted-by":"crossref","unstructured":"Awedew, AF, Han, H, Abbasi, B, Abbasi-Kangevari, M, Ahmed, MB, Almidani, O, et al.. The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the global burden of disease study 2019. Lancet Healthy Longev 2022;3:e754\u201376. https:\/\/doi.org\/10.1016\/s2666-7568(22)00213-6.","DOI":"10.1016\/S2666-7568(22)00213-6"},{"key":"2026011312015838949_j_med-2025-1371_ref_005","doi-asserted-by":"crossref","unstructured":"Kim, EH, Larson, JA, Andriole, GL. Management of benign prostatic hyperplasia. Annu Rev Med 2016;67:137\u201351. https:\/\/doi.org\/10.1146\/annurev-med-063014-123902.","DOI":"10.1146\/annurev-med-063014-123902"},{"key":"2026011312015838949_j_med-2025-1371_ref_006","doi-asserted-by":"crossref","unstructured":"Song, Z, Cheng, ZJ, Yuan, H, Chang, Z, Lv, Y, Huang, X, et al.. Correlation between benign prostatic hyperplasia and comorbidities: a systematic analysis integrating global burden of disease and mendelian randomization study. J\u00a0Transl Med 2024;22:1035. https:\/\/doi.org\/10.1186\/s12967-024-05604-x.","DOI":"10.1186\/s12967-024-05604-x"},{"key":"2026011312015838949_j_med-2025-1371_ref_007","doi-asserted-by":"crossref","unstructured":"De Nunzio, C, Presicce, F, Tubaro, A. Inflammatory mediators in the development and progression of benign prostatic hyperplasia. Nat Rev Urol 2016;13:613\u201326. https:\/\/doi.org\/10.1038\/nrurol.2016.168.","DOI":"10.1038\/nrurol.2016.168"},{"key":"2026011312015838949_j_med-2025-1371_ref_008","doi-asserted-by":"crossref","unstructured":"De Nunzio, C, Kramer, G, Marberger, M, Montironi, R, Nelson, W, Schr\u00f6der, F, et al.. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation. Eur Urol 2011;60:106\u201317. https:\/\/doi.org\/10.1016\/j.eururo.2011.03.055.","DOI":"10.1016\/j.eururo.2011.03.055"},{"key":"2026011312015838949_j_med-2025-1371_ref_009","doi-asserted-by":"crossref","unstructured":"Lanman, NA, Meco, E, Fitchev, P, Kolliegbo, AK, Broman, MM, Filipovich, Y, et al.. Infiltrating lipid-rich macrophage subpopulations identified as a regulator of increasing prostate size in human benign prostatic hyperplasia. Front Immunol 2024;15:1494476. https:\/\/doi.org\/10.3389\/fimmu.2024.1494476.","DOI":"10.3389\/fimmu.2024.1494476"},{"key":"2026011312015838949_j_med-2025-1371_ref_010","doi-asserted-by":"crossref","unstructured":"Middleton, LW, Shen, Z, Varma, S, Pollack, AS, Gong, X, Zhu, S, et al.. Genomic analysis of benign prostatic hyperplasia implicates cellular relandscaping in disease pathogenesis. JCI Insight 2019;5:e129749. https:\/\/doi.org\/10.1172\/jci.insight.129749.","DOI":"10.1172\/jci.insight.129749"},{"key":"2026011312015838949_j_med-2025-1371_ref_011","doi-asserted-by":"crossref","unstructured":"Henry, GH, Malewska, A, Joseph, DB, Malladi, VS, Lee, J, Torrealba, J, et al.. A cellular anatomy of the normal adult human prostate and prostatic urethra. Cell Rep 2018;25:3530\u201342.e5. https:\/\/doi.org\/10.1016\/j.celrep.2018.11.086.","DOI":"10.1016\/j.celrep.2018.11.086"},{"key":"2026011312015838949_j_med-2025-1371_ref_012","doi-asserted-by":"crossref","unstructured":"Burgess, S, Scott, RA, Timpson, NJ, Davey Smith, G, Thompson, SG. Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors. Eur J Epidemiol 2015;30:543\u201352. https:\/\/doi.org\/10.1007\/s10654-015-0011-z.","DOI":"10.1007\/s10654-015-0011-z"},{"key":"2026011312015838949_j_med-2025-1371_ref_013","doi-asserted-by":"crossref","unstructured":"Burgess, S, Butterworth, A, Thompson, SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol 2013;37:658\u201365. https:\/\/doi.org\/10.1002\/gepi.21758.","DOI":"10.1002\/gepi.21758"},{"key":"2026011312015838949_j_med-2025-1371_ref_014","doi-asserted-by":"crossref","unstructured":"Sekula, P, Del Greco, MF, Pattaro, C, K\u00f6ttgen, A. Mendelian randomization as an approach to assess causality using observational data. J\u00a0Am Soc Nephrol 2016;27:3253\u201365. https:\/\/doi.org\/10.1681\/ASN.2016010098.","DOI":"10.1681\/ASN.2016010098"},{"key":"2026011312015838949_j_med-2025-1371_ref_015","doi-asserted-by":"crossref","unstructured":"Doke, T, Huang, S, Qiu, C, Liu, H, Guan, Y, Hu, H, et al.. Transcriptome-wide association analysis identifies DACH1 as a kidney disease risk gene that contributes to fibrosis. J\u00a0Clin Investig 2021;131:e141801. https:\/\/doi.org\/10.1172\/jci141801.","DOI":"10.1172\/JCI141801"},{"key":"2026011312015838949_j_med-2025-1371_ref_016","doi-asserted-by":"crossref","unstructured":"Maurano, MT, Humbert, R, Rynes, E, Thurman, RE, Haugen, E, Wang, H, et al.. Systematic localization of common disease-associated variation in regulatory DNA. Science 2012;337:1190\u20135. https:\/\/doi.org\/10.1126\/science.1222794.","DOI":"10.1126\/science.1222794"},{"key":"2026011312015838949_j_med-2025-1371_ref_017","doi-asserted-by":"crossref","unstructured":"Emilsson, V, Thorleifsson, G, Zhang, B, Leonardson, AS, Zink, F, Zhu, J, et al.. Genetics of gene expression and its effect on disease. Nature 2008;452:423\u20138. https:\/\/doi.org\/10.1038\/nature06758.","DOI":"10.1038\/nature06758"},{"key":"2026011312015838949_j_med-2025-1371_ref_018","doi-asserted-by":"crossref","unstructured":"Giambartolomei, C, Zhenli Liu, J, Zhang, W, Hauberg, M, Shi, H, Boocock, J, et al.. A Bayesian framework for multiple trait colocalization from summary association statistics. Bioinformatics 2018;34:2538\u201345. https:\/\/doi.org\/10.1093\/bioinformatics\/bty147.","DOI":"10.1093\/bioinformatics\/bty147"},{"key":"2026011312015838949_j_med-2025-1371_ref_019","doi-asserted-by":"crossref","unstructured":"Giambartolomei, C, Vukcevic, D, Schadt, EE, Franke, L, Hingorani, AD, Wallace, C, et al.. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet 2014;10:e1004383. https:\/\/doi.org\/10.1371\/journal.pgen.1004383.","DOI":"10.1371\/journal.pgen.1004383"},{"key":"2026011312015838949_j_med-2025-1371_ref_020","doi-asserted-by":"crossref","unstructured":"Joseph, DB, Henry, GH, Malewska, A, Iqbal, NS, Ruetten, HM, Turco, AE, et al.. Urethral luminal epithelia are castration-insensitive cells of the proximal prostate. Prostate 2020;80:872\u201384. https:\/\/doi.org\/10.1002\/pros.24020.","DOI":"10.1002\/pros.24020"},{"key":"2026011312015838949_j_med-2025-1371_ref_021","doi-asserted-by":"crossref","unstructured":"Butler, A, Hoffman, P, Smibert, P, Papalexi, E, Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol 2018;36:411\u201320. https:\/\/doi.org\/10.1038\/nbt.4096.","DOI":"10.1038\/nbt.4096"},{"key":"2026011312015838949_j_med-2025-1371_ref_022","doi-asserted-by":"crossref","unstructured":"Street, K, Risso, D, Fletcher, RB, Das, D, Ngai, J, Yosef, N, et al.. Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics. BMC Genom 2018;19:477. https:\/\/doi.org\/10.1186\/s12864-018-4772-0.","DOI":"10.1186\/s12864-018-4772-0"},{"key":"2026011312015838949_j_med-2025-1371_ref_023","doi-asserted-by":"crossref","unstructured":"Jin, S, Guerrero-Juarez, CF, Zhang, L, Chang, I, Ramos, R, Kuan, CH, et al.. Inference and analysis of cell-cell communication using CellChat. Nat Commun 2021;12:1088. https:\/\/doi.org\/10.1038\/s41467-021-21246-9.","DOI":"10.1038\/s41467-021-21246-9"},{"key":"2026011312015838949_j_med-2025-1371_ref_024","doi-asserted-by":"crossref","unstructured":"Skrivankova, VW, Richmond, RC, Woolf, BAR, Davies, NM, Swanson, SA, VanderWeele, TJ, et al.. Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration. BMJ 2021;375:n2233. https:\/\/doi.org\/10.1136\/bmj.n2233.","DOI":"10.1136\/bmj.n2233"},{"key":"2026011312015838949_j_med-2025-1371_ref_025","doi-asserted-by":"crossref","unstructured":"Hemani, G, Zheng, J, Elsworth, B, Wade, KH, Haberland, V, Baird, D, et al.. The MR-Base platform supports systematic causal inference across the human phenome. eLife 2018;7:e34408. https:\/\/doi.org\/10.7554\/elife.34408.","DOI":"10.7554\/eLife.34408"},{"key":"2026011312015838949_j_med-2025-1371_ref_026","doi-asserted-by":"crossref","unstructured":"Folkersen, L, Fauman, E, Sabater-Lleal, M, Strawbridge, RJ, Fr\u00e5nberg, M, Sennblad, B, et al.. Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease. PLoS Genet 2017;13:e1006706. https:\/\/doi.org\/10.1371\/journal.pgen.1006706.","DOI":"10.1371\/journal.pgen.1006706"},{"key":"2026011312015838949_j_med-2025-1371_ref_027","doi-asserted-by":"crossref","unstructured":"Szklarczyk, D, Kirsch, R, Koutrouli, M, Nastou, K, Mehryary, F, Hachilif, R, et al.. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res 2023;51:D638\u201346. https:\/\/doi.org\/10.1093\/nar\/gkac1000.","DOI":"10.1093\/nar\/gkac1000"},{"key":"2026011312015838949_j_med-2025-1371_ref_028","doi-asserted-by":"crossref","unstructured":"Chen, W, Paradkar, PN, Li, L, Pierce, EL, Langer, NB, Takahashi-Makise, N, et al.. Abcb10 physically interacts with mitoferrin-1 (Slc25a37) to enhance its stability and function in the erythroid mitochondria. Proc Natl Acad Sci USA 2009;106:16263\u20138. https:\/\/doi.org\/10.1073\/pnas.0904519106.","DOI":"10.1073\/pnas.0904519106"},{"key":"2026011312015838949_j_med-2025-1371_ref_029","doi-asserted-by":"crossref","unstructured":"Bao, W, Han, Q, Guan, X, Wang, Z, Gu, M. Solute carrier-related signature for assessing prognosis and immunity in patients with clear-cell renal cell carcinoma. Oncol Res 2023;31:181\u201392. https:\/\/doi.org\/10.32604\/or.2023.028051.","DOI":"10.32604\/or.2023.028051"},{"key":"2026011312015838949_j_med-2025-1371_ref_030","doi-asserted-by":"crossref","unstructured":"Li, C, Zhang, Y, Cheng, X, Yuan, H, Zhu, S, Liu, J, et al.. PINK1 and PARK2 suppress pancreatic tumorigenesis through control of mitochondrial iron-mediated immunometabolism. Dev Cell 2018;46:441\u201355.e8. https:\/\/doi.org\/10.1016\/j.devcel.2018.07.012.","DOI":"10.1016\/j.devcel.2018.07.012"},{"key":"2026011312015838949_j_med-2025-1371_ref_031","doi-asserted-by":"crossref","unstructured":"Ni, S, Kuang, Y, Yuan, Y, Yu, B. Mitochondrion-mediated iron accumulation promotes carcinogenesis and Warburg effect through\u00a0reactive oxygen species in osteosarcoma. Cancer Cell Int 2020;20:399. https:\/\/doi.org\/10.1186\/s12935-020-01494-3.","DOI":"10.1186\/s12935-020-01494-3"},{"key":"2026011312015838949_j_med-2025-1371_ref_032","doi-asserted-by":"crossref","unstructured":"Kramer, G, Mitteregger, D, Marberger, M. Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? Eur Urol 2007;51:1202\u201316. https:\/\/doi.org\/10.1016\/j.eururo.2006.12.011.","DOI":"10.1016\/j.eururo.2006.12.011"},{"key":"2026011312015838949_j_med-2025-1371_ref_033","doi-asserted-by":"crossref","unstructured":"Lin, J, Freeman, MR. Transactivation of ErbB1 and ErbB2 receptors by angiotensin II in normal human prostate stromal cells. Prostate 2003;54:1\u20137. https:\/\/doi.org\/10.1002\/pros.10160.","DOI":"10.1002\/pros.10160"},{"key":"2026011312015838949_j_med-2025-1371_ref_034","doi-asserted-by":"crossref","unstructured":"Mason, JB. Folate, cancer risk, and the greek god, proteus: a tale of two chameleons. Nutr Rev 2009;67:206\u201312. https:\/\/doi.org\/10.1111\/j.1753-4887.2009.00190.x.","DOI":"10.1111\/j.1753-4887.2009.00190.x"},{"key":"2026011312015838949_j_med-2025-1371_ref_035","doi-asserted-by":"crossref","unstructured":"Awwad, HM, Ohlmann, CH, Stoeckle, M, Geisel, J, Obeid, R. Serum concentrations of folate vitamers in patients with a newly diagnosed prostate cancer or hyperplasia. Clin Biochem 2018;56:41\u20136. https:\/\/doi.org\/10.1016\/j.clinbiochem.2018.04.011.","DOI":"10.1016\/j.clinbiochem.2018.04.011"},{"key":"2026011312015838949_j_med-2025-1371_ref_036","doi-asserted-by":"crossref","unstructured":"Tomaszewski, JJ, Cummings, JL, Parwani, AV, Dhir, R, Mason, JB, Nelson, JB, et al.. Increased cancer cell proliferation in prostate cancer patients with high levels of serum folate. Prostate 2011;71:1287\u201393. https:\/\/doi.org\/10.1002\/pros.21346.","DOI":"10.1002\/pros.21346"},{"key":"2026011312015838949_j_med-2025-1371_ref_037","doi-asserted-by":"crossref","unstructured":"Pieroth, R, Paver, S, Day, S, Lammersfeld, C. Folate and its impact on cancer risk. Curr Nutr Rep 2018;7:70\u201384. https:\/\/doi.org\/10.1007\/s13668-018-0237-y.","DOI":"10.1007\/s13668-018-0237-y"},{"key":"2026011312015838949_j_med-2025-1371_ref_038","doi-asserted-by":"crossref","unstructured":"Kim, Y. Folate: a magic bullet or a double edged sword for colorectal cancer prevention? Gut 2006;55:1387\u20139. https:\/\/doi.org\/10.1136\/gut.2006.095463.","DOI":"10.1136\/gut.2006.095463"},{"key":"2026011312015838949_j_med-2025-1371_ref_039","doi-asserted-by":"crossref","unstructured":"Paulick, MG, Bertozzi, CR. The glycosylphosphatidylinositol anchor: a complex membrane-anchoring structure for proteins. Biochemistry 2008;47:6991\u20137000. https:\/\/doi.org\/10.1021\/bi8006324.","DOI":"10.1021\/bi8006324"},{"key":"2026011312015838949_j_med-2025-1371_ref_040","doi-asserted-by":"crossref","unstructured":"Kinoshita, T. Biosynthesis and biology of mammalian GPI-anchored proteins. Open Biol 2020;10:190290. https:\/\/doi.org\/10.1098\/rsob.190290.","DOI":"10.1098\/rsob.190290"},{"key":"2026011312015838949_j_med-2025-1371_ref_041","doi-asserted-by":"crossref","unstructured":"Kokkonen, N, Khosrowabadi, E, Hassinen, A, Harrus, D, Glumoff, T, Kietzmann, T, et al.. Abnormal golgi pH\u00a0homeostasis in cancer cells impairs apical targeting of carcinoembryonic antigen by inhibiting its glycosyl-phosphatidylinositol anchor-mediated association with lipid rafts. Antioxid Redox Signal 2019;30:5\u201321. https:\/\/doi.org\/10.1089\/ars.2017.7389.","DOI":"10.1089\/ars.2017.7389"},{"key":"2026011312015838949_j_med-2025-1371_ref_042","doi-asserted-by":"crossref","unstructured":"Li, N, Spetz, MR, Ho, M. The role of glypicans in cancer progression and therapy. J\u00a0Histochem Cytochem 2020;68:841\u201362. https:\/\/doi.org\/10.1369\/0022155420933709.","DOI":"10.1369\/0022155420933709"}],"container-title":["Open Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/med-2025-1371\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/med-2025-1371\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T12:02:17Z","timestamp":1768305737000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/med-2025-1371\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,13]]},"published-print":{"date-parts":[[2026,1,23]]}},"alternative-id":["10.1515\/med-2025-1371"],"URL":"https:\/\/doi.org\/10.1515\/med-2025-1371","relation":{},"ISSN":["2391-5463"],"issn-type":[{"value":"2391-5463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,1]]},"article-number":"20251371"}}